Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trophozoite export protein 1 (Tex1) is a large, highly conserved protein expressed during the asexual blood stage of the malaria parasite Plasmodium falciparum. It is exported from the parasite to the Maurer's clefts, which are parasite-derived organelles in the host erythrocyte cytoplasm involved in protein trafficking and host cell remodeling. Tex1 contains two major antigenic regions: a coiled-coil domain known as P27 and an intrinsically unstructured region known as P27A. These regions are recognized by antibodies from individuals living in malaria-endemic areas, and these antibodies are associated with clinical protection. The P27A fragment has been developed as a synthetic peptide vaccine candidate and has undergone Phase 1 clinical testing, demonstrating safety and the ability to induce antibodies that inhibit parasite growth through antibody-dependent cellular inhibition (ADCI).
Induction of protective antibodies that inhibit parasite growth through antibody-dependent cellular inhibition (ADCI).
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trophozoite export protein 1 (Tex1).